Henry Meds Review

Henry’s pricing is aggressive relative to branded GLP-1s and fairly competitive within telehealth. Examples from its Programs pages include compounded semaglutide memberships from $199 per month (provider visit, prescription, and support bundled), tirzepatide ODT at $297 per month, and liraglutide or phentermine-based plans ranging from $149 to $297. TRT programs are advertised from roughly $199–$225 monthly with routine labs, while ED ICP therapy memberships list at $149 per month plus medication. The headline prices bundle clinical visits, but shipping, pharmacy transfers, or supplemental lab work can add to the effective cost, so patients should confirm the full invoice before enrolling.

On the clinical model, Henry relies on independent clinicians and licensed US compounding pharmacies; several pages reiterate the non‑FDA‑approved status of compounded drugs and caution against extrapolating from branded‑drug trials—transparent and appropriate disclosures. Packaging may not always be child‑resistant, which Henry flags in its Terms. Shipping is 2‑Day after processing, and most patients receive meds in 8–10 business days.Where quality gets complicated is the nature of compounding itself (variable formulations and supply), and fluctuating availability tied to FDA shortage policy. The FDA determined tirzepatide shortages were resolved on Dec 19, 2024, and semaglutide shortages on Feb 21, 2025, developments that have tightened the rationale for compounding and can affect patient transitions. Henry has also signaled changes to compounded tirzepatide availability tied to supply‑chain shifts. Patients should ask providers which formulation and supplier they’ll receive now and what happens if inventory changes.

The three‑step flow (forms → video visit → doorstep delivery) is straightforward, with provider visits included in program pricing and no insurance required. Support hours are posted clearly (Mon–Sat, 5:00 am–5:00 pm PST), and the FAQ explains invoices and cancellations from the customer portal. A minor deduction reflects variable appointment availability at peak times and the need to navigate multiple pages to reconcile price tiers.

Breadth is a strength within Henry’s chosen lanes:Weight loss/metabolic: compounded semaglutide (injectable, ODT, sublingual drops), tirzepatide (ODT), liraglutide (daily injections), and phentermine ± topiramate (where allowed).TRT & men’s health: injectable testosterone, topical cream, enclomiphene, and KYZATREX™ oral options. Women’s HRT: listed program from $149/mo.ED: ICP injection therapy (Bimix/Trimix/Quadmix) under a $149/mo membership.Henry does not advertise dermatology, hair‑loss, or broad wellness‑injectable catalogs, which may matter if you want a single clinic for everything. (We also did not find public pages offering PDE‑5 tablets like sildenafil/tadalafil; the ED focus is ICP.)

Henry sets expectations well: 2‑Day shipping after processing; 8–10 business days door‑to‑door for most patients; California orders may take longer (extra testing). Refills are auto‑shipped monthly unless your provider changes the plan. We dock one point because fulfillment timelines can lengthen during pharmacy supply shifts—a reality for compounded meds.

You can reach Henry by phone or email during posted hours, and the site explains how to handle billing questions and cancellations. However, external complaint boards describe uneven responsiveness and billing disputes, while broader review platforms also show many positive experiences. The mixed signal yields a middle‑of‑the‑road score here.

The design is clean, the Programs page spells out inclusions, and the workflow from intake to telehealth visit is intuitive. Minor UX friction: reconciling pricing across marketing and Programs pages, and the need to drill into policy pages to understand cancellation and refund nuances.